Issuer · CIK 0001395937

SNDX — Syndax Pharmaceuticals Inc

Recent filings

Jul 9, 2026·Form 4·Sell$784.8K
SNDX/Syndax Pharmaceuticals Inc
Metzger Michael A · Chief Executive Officer
Mechanical filing
AI thesis skipped
Jun 12, 2026·Form 4·Sell$617K
SNDX/Syndax Pharmaceuticals Inc
Botwood Nicholas A.J. · Head of R&D, CMO
Mechanical filing
AI thesis skipped

← Back to all filings